Promoting physical activity for people with haemophilia in the age of new treatments.

behaviour haemophilia life stages physical activity physical activity promotion

Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 12 07 2022
received: 21 04 2022
accepted: 13 07 2022
pubmed: 28 7 2022
medline: 16 11 2022
entrez: 27 7 2022
Statut: ppublish

Résumé

Haemophilia treatment has seen great advances in recent years with an accompanied reduced risk of physical activity (PA) related bleeds. Based on its known health benefits, people with haemophilia (PWH) are currently encouraged to regularly engage in PA. However, this may not always translate to increased levels of PA. In this narrative review we aim to provide a brief overview of what is currently understood regarding PA levels and influences for the three broad age groups of children and adolescents, adults and older adults. We also provide recommendations for members of the haemophilia team on important aspects related to promotion of PA in their clinical practice. We highlight that PA behaviour is multifactorial and that many PWH still have limited access to adequate care. Whilst some still face unique challenges to being more physically active, overall, the barriers and facilitators to activity are very similar to that of the general population.

Identifiants

pubmed: 35896000
doi: 10.1111/hae.14641
pmc: PMC9796679
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

885-890

Informations de copyright

© 2022 The Authors. Haemophilia published by John Wiley & Sons Ltd.

Références

Patient Prefer Adherence. 2020 Jan 23;14:163-171
pubmed: 32158199
Haemophilia. 2020 Aug;26 Suppl 6:1-158
pubmed: 32744769
JAMA. 2012 Oct 10;308(14):1452-9
pubmed: 23047359
Blood. 2015 Mar 26;125(13):2038-44
pubmed: 25712992
Haemophilia. 2013 Jul;19(4):487-98
pubmed: 23534844
Haemophilia. 2021 Jul;27(4):544-562
pubmed: 33751742
Disabil Rehabil. 2017 Aug;39(17):1771-1784
pubmed: 27442686
BMC Public Health. 2018 Oct 2;18(Suppl 2):1034
pubmed: 30285701
Haemophilia. 2009 May;15(3):686-94
pubmed: 19432922
Haemophilia. 2007 May;13(3):323-7
pubmed: 17498083
Haemophilia. 2021 Sep;27(5):876-885
pubmed: 34146370
Haemophilia. 2009 Jan;15 Suppl 1:15-9
pubmed: 19125936
JAMA. 2012 Oct 10;308(14):1480-1
pubmed: 23047364
J Clin Med. 2021 Jun 26;10(13):
pubmed: 34206923
Eur J Haematol. 2017 Apr;98 Suppl 86:25-34
pubmed: 28319336
Haemophilia. 2007 Sep;13 Suppl 2:47-52
pubmed: 17685925
Lancet. 2012 Jul 21;380(9838):258-71
pubmed: 22818938
Haemophilia. 2006 May;12(3):237-40
pubmed: 16643207
Int J Behav Nutr Phys Act. 2021 Jun 29;18(1):81
pubmed: 34187486
Haemophilia. 2022 Nov;28(6):885-890
pubmed: 35896000
Int J Behav Med. 2015 Feb;22(1):32-50
pubmed: 24788314
Psychol Rev. 1977 Mar;84(2):191-215
pubmed: 847061
Haemophilia. 2013 Jul;19(4):551-7
pubmed: 23574421
Haemophilia. 2003 Sep;9(5):555-66
pubmed: 14511294
Disabil Rehabil. 2022 Dec;44(26):8420-8428
pubmed: 34951552
J Comorb. 2011 Dec 27;1:51-59
pubmed: 29090136
Pediatrics. 2009 Nov;124(5):1267-72
pubmed: 19822585
Eur J Haematol. 2022 Jun;108(6):518-527
pubmed: 35258118
Disabil Rehabil. 2022 Nov;44(23):7237-7245
pubmed: 34651530
Haemophilia. 2007 Sep;13 Suppl 2:38-43
pubmed: 17685923
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
Gerontologist. 2016 Apr;56 Suppl 2:S268-80
pubmed: 26994266
Transl Pediatr. 2017 Jul;6(3):174-180
pubmed: 28795008
Am J Prev Med. 2011 Dec;41(6 Suppl 4):S369-75
pubmed: 22099360
Lancet. 2012 Jul 21;380(9838):193-5
pubmed: 22818934
Thromb Res. 2014 Nov;134 Suppl 1:S61-7
pubmed: 24726553
Br J Sports Med. 2022 Apr;56(8):427-438
pubmed: 34649919
Res Pract Thromb Haemost. 2017 Dec 04;2(1):147-154
pubmed: 30046715
Age Ageing. 2017 Jan 20;46(1):71-77
pubmed: 28181637
Blood. 2017 Nov 23;130(21):2251-2256
pubmed: 29018078
Disabil Rehabil. 2022 Dec;44(26):8412-8419
pubmed: 34951551
Lancet Child Adolesc Health. 2020 Jan;4(1):23-35
pubmed: 31761562
Br J Sports Med. 2020 Dec;54(24):1451-1462
pubmed: 33239350
Public Health Rep. 1985 Mar-Apr;100(2):126-31
pubmed: 3920711
Blood Coagul Fibrinolysis. 2016 Oct;27(7):737-744
pubmed: 27116081
BMC Public Health. 2006 May 23;6:138
pubmed: 16719900
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Blood Coagul Fibrinolysis. 2020 Dec;31(8):522-529
pubmed: 32941196
Gerontologist. 2015 Dec;55(6):901-11
pubmed: 26561272
Lancet Glob Health. 2018 Oct;6(10):e1077-e1086
pubmed: 30193830
Haemophilia. 2020 Jul;26(4):718-725
pubmed: 32364278
Haemophilia. 2010 Jul 1;16(4):656-61
pubmed: 20331760

Auteurs

Ruth Elise D Matlary (RED)

Department of Haematology, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Nathalie Grinda (N)

Haemophilia Reference Centre, Bicêtre Hospital AP-HP University Paris XI, Paris, France.

Fionnuala Sayers (F)

Haemophilia Comprehensive Care Centre, Belfast Health and Social Care Trust, Belfast, UK.

Olav Versloot (O)

Centre for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Department of Physiotherapy, Institute of Movement Studies, University of Applied Science, Utrecht, the Netherlands.

Paul McLaughlin (P)

Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH